HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yingxue Chen Selected Research

ganirelix

10/2019[Effects of cetrorelix versus ganirelix in gonadotropin-releasing hormone antagonist cycles for preventing premature luteinizing hormone surges and on clinical outcomes of IVF-ET cycles].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yingxue Chen Research Topics

Disease

4Asthma (Bronchial Asthma)
01/2022 - 01/2016
1Neoplasms (Cancer)
01/2022
1Malignant Mesothelioma
01/2022
1Ovarian Hyperstimulation Syndrome
10/2019
1Inflammation (Inflammations)
02/2019
1Chronic Obstructive Pulmonary Disease (COPD)
01/2019
1Ataxia Telangiectasia (Louis Bar Syndrome)
10/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2016
1Infections
01/2016

Drug/Important Bio-Agent (IBA)

3velsecoratIBA
01/2022 - 01/2019
3Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2022 - 01/2019
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2022
1Biomarkers (Surrogate Marker)IBA
01/2022
1tazemetostatIBA
01/2022
1Pemetrexed (MTA)FDA Link
01/2022
1cetrorelix (Cetrotide)FDA Link
10/2019
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2019
1ganirelixFDA Link
10/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
02/2019
1Bronchodilator Agents (Bronchodilators)IBA
02/2019
1PyransIBA
10/2018
1AZD0156IBA
10/2018
1Phosphotransferases (Kinase)IBA
10/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2018
1Gefitinib (Iressa)FDA Link
01/2018
1Testosterone (Sustanon)FDA Link
01/2016

Therapy/Procedure

1Aftercare (After-Treatment)
01/2022
1Therapeutics
01/2022
1Length of Stay
01/2016
1Patient Discharge
01/2016